Annual report
9627.TEDINET S100OTEG
Period2021-05-01 → 2022-04-30
Filed2022-07-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥316.2bn | 2021-05-01 → 2022-04-30 | Cons. | Net sales |
| Revenue | ¥297.3bn | 2020-05-01 → 2021-04-30 | Cons. | Net sales |
| Revenue | ¥292.6bn | 2019-05-01 → 2020-04-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥275.6bn | 2018-05-01 → 2019-04-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥268.4bn | 2017-05-01 → 2018-04-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥15.1bn | 2021-05-01 → 2022-04-30 | Cons. | Operating income |
| Operating income | ¥10.9bn | 2020-05-01 → 2021-04-30 | Cons. | Operating income |
| Ordinary income | ¥16.0bn | 2021-05-01 → 2022-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥12.6bn | 2020-05-01 → 2021-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.8bn | 2019-05-01 → 2020-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.6bn | 2018-05-01 → 2019-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.1bn | 2017-05-01 → 2018-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥13.1bn | 2021-05-01 → 2022-04-30 | Cons. | Income before income taxes |
| Profit before tax | ¥11.8bn | 2020-05-01 → 2021-04-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.1bn | 2021-05-01 → 2022-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.7bn | 2020-05-01 → 2021-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2019-05-01 → 2020-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.0bn | 2018-05-01 → 2019-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.6bn | 2017-05-01 → 2018-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥7.1bn | 2021-05-01 → 2022-04-30 | Cons. | Profit loss |
| Net income | ¥6.7bn | 2020-05-01 → 2021-04-30 | Cons. | Profit loss |
| Total assets | ¥212.5bn | at 2022-04-30 | Cons. | Assets |
| Total assets | ¥203.7bn | at 2021-04-30 | Cons. | Assets |
| Total assets | ¥193.5bn | at 2020-04-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥189.0bn | at 2019-04-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥183.4bn | at 2018-04-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥93.5bn | at 2022-04-30 | Cons. | Liabilities |
| Total liabilities | ¥87.8bn | at 2021-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥119.0bn | at 2022-04-30 | Cons. | Net assets |
| Net assets / equity | ¥115.8bn | at 2021-04-30 | Cons. | Net assets |
| Net assets / equity | ¥111.0bn | at 2020-04-30d | Cons. | Net assets |
| Net assets / equity | ¥103.9bn | at 2019-04-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥96.7bn | at 2018-04-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥59.7bn | at 2022-04-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥55.3bn | at 2021-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥59.5bn | at 2022-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥55.0bn | at 2021-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥45.9bn | at 2020-04-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥47.5bn | at 2019-04-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥63.2bn | at 2018-04-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥26.2bn | 2021-05-01 → 2022-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥14.9bn | 2020-05-01 → 2021-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥17.7bn | 2019-05-01 → 2020-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.8bn | 2018-05-01 → 2019-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥21.7bn | 2017-05-01 → 2018-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥13.9bn | 2021-05-01 → 2022-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥9.5bn | 2020-05-01 → 2021-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.5bn | 2019-05-01 → 2020-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥20.0bn | 2018-05-01 → 2019-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.3bn | 2017-05-01 → 2018-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥7.8bn | 2021-05-01 → 2022-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.6bn | 2020-05-01 → 2021-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.8bn | 2019-05-01 → 2020-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥10.7bn | 2018-05-01 → 2019-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥17.6bn | 2017-05-01 → 2018-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥201.47 | 2021-05-01 → 2022-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.04 | 2020-05-01 → 2021-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥259.11 | 2019-05-01 → 2020-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥254.87 | 2018-05-01 → 2019-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥310.08 | 2017-05-01 → 2018-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,385.51 | at 2022-04-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,267.49 | at 2021-04-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,130.77 | at 2020-04-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,931.48 | at 2019-04-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,729.44 | at 2018-04-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 56.0% | at 2022-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.8% | at 2021-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.3% | at 2020-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.9% | at 2019-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2018-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.0% | 2021-05-01 → 2022-04-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-05-01 → 2021-04-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-05-01 → 2020-04-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.0% | 2018-05-01 → 2019-04-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.5% | 2017-05-01 → 2018-04-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 9,568 | at 2022-04-30 | Cons. | Number of employees |
| Employees | 9,019 | at 2021-04-30 | Cons. | Number of employees |
| Employees | 8,406 | at 2020-04-30d | Cons. | Number of employees |
| Employees | 7,662 | at 2019-04-30d | Cons. | Number of employees |
| Employees | 6,498 | at 2018-04-30d | Cons. | Number of employees |
| Revenue | ¥11.5bn | 2021-05-01 → 2022-04-30 | Standalone | Operating revenue1 |
| Revenue | ¥11.6bn | 2020-05-01 → 2021-04-30 | Standalone | Operating revenue1 |
| Revenue | ¥10.3bn | 2019-05-01 → 2020-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥10.5bn | 2018-05-01 → 2019-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥7.3bn | 2017-05-01 → 2018-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥5.0bn | 2021-05-01 → 2022-04-30 | Standalone | Operating income |
| Operating income | ¥6.0bn | 2020-05-01 → 2021-04-30 | Standalone | Operating income |
| Ordinary income | ¥5.2bn | 2021-05-01 → 2022-04-30 | Standalone | Ordinary income |
| Ordinary income | ¥6.3bn | 2020-05-01 → 2021-04-30 | Standalone | Ordinary income |
| Ordinary income | ¥5.8bn | 2019-05-01 → 2020-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2018-05-01 → 2019-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.0bn | 2017-05-01 → 2018-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.1bn | 2021-05-01 → 2022-04-30 | Standalone | Income before income taxes |
| Profit before tax | ¥6.3bn | 2020-05-01 → 2021-04-30 | Standalone | Income before income taxes |
| Net income | ¥5.0bn | 2021-05-01 → 2022-04-30 | Standalone | Profit loss |
| Net income | ¥6.1bn | 2020-05-01 → 2021-04-30 | Standalone | Profit loss |
| Net income | ¥5.5bn | 2019-05-01 → 2020-04-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.6bn | 2018-05-01 → 2019-04-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.9bn | 2017-05-01 → 2018-04-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥140.2bn | at 2022-04-30 | Standalone | Assets |
| Total assets | ¥136.4bn | at 2021-04-30 | Standalone | Assets |
| Total assets | ¥121.3bn | at 2020-04-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥118.2bn | at 2019-04-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥123.0bn | at 2018-04-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥62.0bn | at 2022-04-30 | Standalone | Liabilities |
| Total liabilities | ¥59.2bn | at 2021-04-30 | Standalone | Liabilities |
| Net assets / equity | ¥78.2bn | at 2022-04-30 | Standalone | Net assets |
| Net assets / equity | ¥77.3bn | at 2021-04-30 | Standalone | Net assets |
| Net assets / equity | ¥73.0bn | at 2020-04-30d | Standalone | Net assets |
| Net assets / equity | ¥69.6bn | at 2019-04-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥64.8bn | at 2018-04-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥46.9bn | at 2022-04-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥41.6bn | at 2021-04-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥141.15 | 2021-05-01 → 2022-04-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.16 | 2020-05-01 → 2021-04-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥154.31 | 2019-05-01 → 2020-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.77 | 2018-05-01 → 2019-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.87 | 2017-05-01 → 2018-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥55 | 2021-05-01 → 2022-04-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2020-05-01 → 2021-04-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2019-05-01 → 2020-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2018-05-01 → 2019-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2017-05-01 → 2018-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,227.25 | at 2022-04-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,180.74 | at 2021-04-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,061.88 | at 2020-04-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,964.69 | at 2019-04-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,830.51 | at 2018-04-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.8% | at 2022-04-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2021-04-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2020-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2019-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2018-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.4% | 2021-05-01 → 2022-04-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-05-01 → 2021-04-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2019-05-01 → 2020-04-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2018-05-01 → 2019-04-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2017-05-01 → 2018-04-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 35,428,212 | at 2022-04-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2021-04-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2020-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2019-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2018-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 160 | at 2022-04-30 | Standalone | Number of employees |
| Employees | 156 | at 2021-04-30 | Standalone | Number of employees |
| Employees | 151 | at 2020-04-30d | Standalone | Number of employees |
| Employees | 143 | at 2019-04-30d | Standalone | Number of employees |
| Employees | 139 | at 2018-04-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 66
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2021-05-01 → 2022-04-30 | ¥435m |
| Otherother segments | depreciation | 2021-05-01 → 2022-04-30 | ¥287m |
| Otherother segments | revenue | 2021-05-01 → 2022-04-30 | ¥12.7bn |
| Otherother segments | revenue external | 2021-05-01 → 2022-04-30 | ¥12.6bn |
| Otherother segments | revenue intersegment | 2021-05-01 → 2022-04-30 | ¥100m |
| Otherother segments | segment assets | at 2022-04-30 | ¥9.3bn |
| Otherother segments | segment ordinary income | 2021-05-01 → 2022-04-30 | −¥146m |
| Reconciling Itemsreconciling | capex | 2021-05-01 → 2022-04-30 | ¥1.3bn |
| Reconciling Itemsreconciling | depreciation | 2021-05-01 → 2022-04-30 | ¥517m |
| Reconciling Itemsreconciling | revenue | 2021-05-01 → 2022-04-30 | −¥100m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-05-01 → 2022-04-30 | −¥100m |
| Reconciling Itemsreconciling | segment assets | at 2022-04-30 | ¥24.2bn |
| Reconciling Itemsreconciling | segment ordinary income | 2021-05-01 → 2022-04-30 | −¥7.1bn |
| Dispensing Pharmacyreportable segment | capex | 2021-05-01 → 2022-04-30 | ¥6.2bn |
| Dispensing Pharmacyreportable segment | depreciation | 2021-05-01 → 2022-04-30 | ¥2.5bn |
| Dispensing Pharmacyreportable segment | employees | at 2022-04-30 | 8485 pure |
| Dispensing Pharmacyreportable segment | revenue | 2021-05-01 → 2022-04-30 | ¥283.1bn |
| Dispensing Pharmacyreportable segment | revenue external | 2021-05-01 → 2022-04-30 | ¥283.1bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2022-04-30 | ¥166.2bn |
| Dispensing Pharmacyreportable segment | segment ordinary income | 2021-05-01 → 2022-04-30 | ¥25.1bn |
| Drug And Cosmetic Storereportable segment | capex | 2021-05-01 → 2022-04-30 | ¥1.0bn |
| Drug And Cosmetic Storereportable segment | depreciation | 2021-05-01 → 2022-04-30 | ¥534m |
| Drug And Cosmetic Storereportable segment | employees | at 2022-04-30 | 667 pure |
| Drug And Cosmetic Storereportable segment | revenue | 2021-05-01 → 2022-04-30 | ¥20.6bn |
| Drug And Cosmetic Storereportable segment | revenue external | 2021-05-01 → 2022-04-30 | ¥20.6bn |
| Drug And Cosmetic Storereportable segment | segment assets | at 2022-04-30 | ¥12.8bn |
| Drug And Cosmetic Storereportable segment | segment ordinary income | 2021-05-01 → 2022-04-30 | −¥1.8bn |
| —segment total | capex | 2021-05-01 → 2022-04-30 | ¥7.6bn |
| —segment total | depreciation | 2021-05-01 → 2022-04-30 | ¥3.4bn |
| —segment total | revenue | 2021-05-01 → 2022-04-30 | ¥316.3bn |
| —segment total | revenue external | 2021-05-01 → 2022-04-30 | ¥316.2bn |
| —segment total | revenue intersegment | 2021-05-01 → 2022-04-30 | ¥100m |
| —segment total | segment assets | at 2022-04-30 | ¥188.3bn |
| —segment total | segment ordinary income | 2021-05-01 → 2022-04-30 | ¥23.2bn |
| Otherother segments | capex | 2020-05-01 → 2021-04-30 | ¥352m |
| Otherother segments | depreciation | 2020-05-01 → 2021-04-30 | ¥303m |
| Otherother segments | revenue | 2020-05-01 → 2021-04-30 | ¥14.9bn |
| Otherother segments | revenue external | 2020-05-01 → 2021-04-30 | ¥14.8bn |
| Otherother segments | revenue intersegment | 2020-05-01 → 2021-04-30 | ¥103m |
| Otherother segments | segment assets | at 2021-04-30 | ¥9.5bn |
| Otherother segments | segment ordinary income | 2020-05-01 → 2021-04-30 | −¥721m |
| Reconciling Itemsreconciling | capex | 2020-05-01 → 2021-04-30 | ¥1.0bn |
| Reconciling Itemsreconciling | depreciation | 2020-05-01 → 2021-04-30 | ¥291m |
| Reconciling Itemsreconciling | revenue | 2020-05-01 → 2021-04-30 | −¥103m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-05-01 → 2021-04-30 | −¥103m |
| Reconciling Itemsreconciling | segment assets | at 2021-04-30 | ¥19.4bn |
| Reconciling Itemsreconciling | segment ordinary income | 2020-05-01 → 2021-04-30 | −¥5.6bn |
| Dispensing Pharmacyreportable segment | capex | 2020-05-01 → 2021-04-30 | ¥3.3bn |
| Dispensing Pharmacyreportable segment | depreciation | 2020-05-01 → 2021-04-30 | ¥2.6bn |
| Dispensing Pharmacyreportable segment | revenue | 2020-05-01 → 2021-04-30 | ¥263.1bn |
| Dispensing Pharmacyreportable segment | revenue external | 2020-05-01 → 2021-04-30 | ¥263.1bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2021-04-30 | ¥161.5bn |
| Dispensing Pharmacyreportable segment | segment ordinary income | 2020-05-01 → 2021-04-30 | ¥20.9bn |
| Drug And Cosmetic Storereportable segment | capex | 2020-05-01 → 2021-04-30 | ¥1.2bn |
| Drug And Cosmetic Storereportable segment | depreciation | 2020-05-01 → 2021-04-30 | ¥536m |
| Drug And Cosmetic Storereportable segment | revenue | 2020-05-01 → 2021-04-30 | ¥19.4bn |
| Drug And Cosmetic Storereportable segment | revenue external | 2020-05-01 → 2021-04-30 | ¥19.4bn |
| Drug And Cosmetic Storereportable segment | segment assets | at 2021-04-30 | ¥13.3bn |
| Drug And Cosmetic Storereportable segment | segment ordinary income | 2020-05-01 → 2021-04-30 | −¥2.0bn |
| —segment total | capex | 2020-05-01 → 2021-04-30 | ¥4.9bn |
| —segment total | depreciation | 2020-05-01 → 2021-04-30 | ¥3.4bn |
| —segment total | revenue | 2020-05-01 → 2021-04-30 | ¥297.4bn |
| —segment total | revenue external | 2020-05-01 → 2021-04-30 | ¥297.3bn |
| —segment total | revenue intersegment | 2020-05-01 → 2021-04-30 | ¥103m |
| —segment total | segment assets | at 2021-04-30 | ¥184.3bn |
| —segment total | segment ordinary income | 2020-05-01 → 2021-04-30 | ¥18.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,595
| Item | Context | Value | Unit |
|---|---|---|---|
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)011（814）1000（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)代表取締役専務 水島 利英 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)札幌市白石区東札幌５条２丁目４番30号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)011（814）1000（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)代表取締役専務 水島 利英 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E04896 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 96270 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社アインホールディングス | |
| Filer name in english | FilingDateInstant | AIN HOLDINGS INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2021-05-01 | |
| Current period end date | FilingDateInstant | 2022-04-30 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2022-04-30 | |
| Previous fiscal year start date | FilingDateInstant | 2020-05-01 | |
| Comparative period end date | FilingDateInstant | 2021-04-30 | |
| Previous fiscal year end date | FilingDateInstant | 2021-04-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場札幌証券取引所 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |